Ophthotech Corp (NASDAQ:OPHT)

2.96
Delayed Data
As of Jun 19
 -0.06 / -1.99%
Today’s Change
2.25
Today|||52-Week Range
4.50
-5.13%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$97.9M

Company Description

Ophthotech Corp. is a biopharmaceutical company,which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.

Contact Information

Ophthotech Corp.
One Penn Plaza
New York New York 10119
P:(212) 845-8200
Investor Relations:
(212) 845-8231

Employees

Shareholders

Other institutional50.71%
Individual stakeholders36.25%
Mutual fund holders11.10%

Top Executives

Glenn P. SblendorioPresident & Chief Executive Officer
Keith WestbyChief Operating Officer & Senior Vice President
David F. CarrollCFO, Treasurer, Principal Accounting Officer & SVP
Amy SheehanChief Human Resources Officer & Senior VP
Todd D. C. AndermanSecretary, Vice President & General Counsel